Cisplatin Market
Cisplatin Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
Cisplatin Market Size and Growth
The Cisplatin market is experiencing growth due to rising cancer incidences and advancements in oncology treatments. Current market size is estimated at approximately $1.6 billion, with projections indicating continued expansion driven by increasing demand for effective chemotherapy options and ongoing research in combination therapies and drug formulations. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Eli Lilly and Company
◍ Hospira
◍ Pfizer
◍ Bedford Pharmaceuticals
◍ Alvogen
◍ Athenex Pharmaceutical
◍ Gland Pharma (Fosun Pharma)
◍ West-Ward Pharmaceuticals
◍ WG Critical Care
◍ David Bull Laboratories
◍ Omega Laboratories
◍ Fresenius Kabi
◍ TEVA
◍ Mylan Pharmaceuticals
◍ Yunnan Plant Pharmaceutical
The Cisplatin market is competitive, with companies like Pfizer, Eli Lilly, and Fresenius Kabi leading. They manufacture and supply cisplatin formulations, enhancing accessibility and affordability. Revenue contributions include:
- Pfizer: ~ $52 billion
- Teva: ~$17 billion
- Mylan: ~$11.5 billion
- Fresenius Kabi: ~ $7 billion.
These firms drive growth through innovation and market expansion.
◍ Yunnan Biological Valley Pharmaceutical
◍ Dezhou de Pharmaceutical
Request Sample Report
◍ Jiangsu Haosen Pharmaceutical Group
Market Segmentation
By Application
Testicular Cancer
Osteosarcoma
Breast Cancer
Request Sample Report
By Product
Tablets
Injection
Market Growth
Request Sample Report
$ X Billion USD
